TELA Bio Statistics

Total Valuation

TELA Bio has a market cap or net worth of $34.90 million. The enterprise value is $42.59 million.

Market Cap	34.90M
Enterprise Value	42.59M

Important Dates

The next confirmed earnings date is Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

TELA Bio has 44.74 million shares outstanding. The number of shares has increased by 64.58% in one year.

Current Share Class	44.74M
Shares Outstanding	44.74M
Shares Change (YoY)	+64.58%
Shares Change (QoQ)	+13.79%
Owned by Insiders (%)	8.42%
Owned by Institutions (%)	24.35%
Float	19.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.45
Forward PS	0.40
PB Ratio	5.64
P/TBV Ratio	7.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.20, with a Debt / Equity ratio of 9.13.

Current Ratio	4.20
Quick Ratio	3.40
Debt / Equity	9.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.44

Financial Efficiency

Return on equity (ROE) is -223.35% and return on invested capital (ROIC) is -31.47%.

Return on Equity (ROE)	-223.35%
Return on Assets (ROA)	-25.12%
Return on Invested Capital (ROIC)	-31.47%
Return on Capital Employed (ROCE)	-53.21%
Weighted Average Cost of Capital (WACC)	8.15%
Revenue Per Employee	$384,091
Profits Per Employee	-$185,794
Employee Count	209
Asset Turnover	0.96
Inventory Turnover	2.15

Taxes

In the past 12 months, TELA Bio has paid $230,000 in taxes.

Income Tax	230,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.72% in the last 52 weeks. The beta is 0.99, so TELA Bio's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	-18.72%
50-Day Moving Average	0.73
200-Day Moving Average	1.22
Relative Strength Index (RSI)	58.17
Average Volume (20 Days)	180,558

Short Selling Information

The latest short interest is 756,594, so 1.69% of the outstanding shares have been sold short.

Short Interest	756,594
Short Previous Month	690,940
Short % of Shares Out	1.69%
Short % of Float	3.89%
Short Ratio (days to cover)	3.64

Income Statement

In the last 12 months, TELA Bio had revenue of $80.28 million and -$38.83 million in losses. Loss per share was -$0.83.

Revenue	80.28M
Gross Profit	54.72M
Operating Income	-33.76M
Pretax Income	-38.60M
Net Income	-38.83M
EBITDA	-32.75M
EBIT	-33.76M
Loss Per Share	-$0.83

Full Income Statement

Balance Sheet

The company has $50.85 million in cash and $57.65 million in debt, giving a net cash position of -$6.81 million or -$0.15 per share.

Cash & Cash Equivalents	50.85M
Total Debt	57.65M
Net Cash	-6.81M
Net Cash Per Share	-$0.15
Equity (Book Value)	6.31M
Book Value Per Share	0.14
Working Capital	57.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.22 million and capital expenditures -$448,000, giving a free cash flow of -$28.67 million.

Operating Cash Flow	-28.22M
Capital Expenditures	-448,000
Depreciation & Amortization	1.01M
Net Borrowing	17.58M
Free Cash Flow	-28.67M
FCF Per Share	-$0.64

Full Cash Flow Statement

Margins

Gross margin is 68.17%, with operating and profit margins of -42.05% and -48.37%.

Gross Margin	68.17%
Operating Margin	-42.05%
Pretax Margin	-48.09%
Profit Margin	-48.37%
EBITDA Margin	-40.79%
EBIT Margin	-42.05%
FCF Margin	n/a

Dividends & Yields

TELA Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-64.58%
Shareholder Yield	-64.58%
Earnings Yield	-108.53%
FCF Yield	-80.12%

Analyst Forecast

The average price target for TELA Bio is $2.00, which is 156.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.00
Price Target Difference	156.41%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TELA Bio has an Altman Z-Score of -5.83 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.83
Piotroski F-Score	3